| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Hadassah Medical Organization |
| Information provided by: | Hadassah Medical Organization |
| ClinicalTrials.gov Identifier: | NCT00254839 |
Purpose
Malodor production is bacterial in origin. The bacterial activity of anaerobic bacteria results in the breakdown of proteins and the production of foul smelling compounds. The aim of the study is to test the hypothesis that bacterial growth on dental implants contributes to malodor production and to see whether this contribution is associated with various properties of the dental implant such as: maker, type, depth ext.
| Condition |
|
Halitosis |
| Study Type: | Observational |
| Study Design: | Cross-Sectional, Convenience Sample, Prospective Study |
| Official Title: | Bacterial Accumulation and Malodor Production in Various Types of Dental Implants |
Eligibility
| Ages Eligible for Study: | 25 Years to 75 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:Dental patients that need dental implants -
Exclusion Criteria:smokers
-
Contacts and Locations| Israel | |||||
| Hadasssah Medical Organization | |||||
| Jerusalem, Israel, 91120 | |||||
| Hadassah Medical Organization |
| Principal Investigator: | Nir Sterer, Dr. | Hadassah - Hebrew University School of Dental medicine |
More Information
| Study ID Numbers: | 01-05-HMO-CTIL |
| First Received: | November 16, 2005 |
| Last Updated: | September 14, 2006 |
| ClinicalTrials.gov Identifier: | NCT00254839 |
| Health Authority: | Israel: Israeli Health Ministry Pharmaceutical Administration |
|
|
|
